{"id":1115,"date":"2021-10-15T12:39:12","date_gmt":"2021-10-15T10:39:12","guid":{"rendered":"http:\/\/haavind.local\/en\/2021\/10\/15\/new-edition-of-haavinds-pharma-report\/"},"modified":"2022-07-21T12:50:50","modified_gmt":"2022-07-21T12:50:50","slug":"new-edition-of-haavinds-pharma-report","status":"publish","type":"post","link":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/","title":{"rendered":"New edition of Haavind\u2019s Pharma Report"},"content":{"rendered":"\t
\n\t\t
\n\t\t\t
\n\t\t\t\t

New edition of Haavind\u2019s Pharma Report<\/h1>\n\n

Welcome to the Autumn 2021 edition of Haavind\u2019s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published twice a year since 2016.
\r\n
\r\n<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t

<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t\t15 October, 2021 \u00b7 2 min. reading time<\/span>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\n
\n\t\t\t\tWritten by<\/span>\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\n\t\t\t\t\t\t
\n\t\t\t\t\t\tH\u00e5kon Austdal<\/span>\n\t\t\t\t\t\tSpecialist Counsel<\/span>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a><\/div>\n\t\t\t\t
\n\t\t\t\t<\/span>\n\t\t\t\t
<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\n

Welcome to the Autumn 2021 edition of Haavind\u2019s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published twice a year since 2016.
\r\n
\r\n<\/p>\n\n\n

\"\"<\/figure><\/div>\n\n\n

In the Autumn 2021 edition, we take a closer look on the recently implemented legislation to allow for interchangeability on biological medicines. You can also read about the new regime on administrative sanctions for violations of certain aspects of pharmaceutical law. In addition, you can read about a patent case concerning a melatonin formulation, as well as a pharmaceutical company\u2019s attempt to challenge the amendment from non-prescription to prescription status for a popular medicinal product.Read the Pharma Report Autumn 2021 here<\/strong><\/a>Download the Pharma Report Autumn 2021 here<\/strong><\/a><\/p>\n\n\n\n

Haavind\u2019s Health and Life Science team continuously and closely monitors developments in Norway relevant to the pharma sector. If you wish to discuss how your business can best meet the legal challenges of this innovative and highly regulated sector, you are always welcome to contact us.<\/em><\/p>\n\n\t

\n\t\t

Contact us<\/h2>\n\t\t
\n\t\t\t
\n
\n\t\n\t
\"\"<\/figure>\n\t<\/a>\n<\/div>\n\n\n
\n\t

Vebj\u00f8rn Krag Iversen<\/h2><\/a>\n\t
Partner<\/a><\/div>\n\t
v.iversen@haavind.stage01.dekodes.no<\/a><\/div>
+47 909 15 129<\/a><\/div><\/div>\n<\/div>\n\n<\/div>\n
\n
\n\t\n\t
\"\"<\/figure>\n\t<\/a>\n<\/div>\n\n\n
\n\t

H\u00e5kon Austdal<\/h2><\/a>\n\t
Specialist Counsel<\/a><\/div>\n\t
h.austdal@haavind.stage01.dekodes.no<\/a><\/div>
+47 920 19 526<\/a><\/div><\/div>\n<\/div>\n\n<\/div><\/div>\t\t<\/div>\n\t\t\t<\/div>\n\t","protected":false},"excerpt":{"rendered":"

Welcome to the Autumn 2021 edition of Haavind\u2019s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published twice a year since 2016.<\/p>\n","protected":false},"author":0,"featured_media":1810,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"sector":[],"speciality":[],"acf":[],"yoast_head":"\nNew edition of Haavind\u2019s Pharma Report - Haavind EN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New edition of Haavind\u2019s Pharma Report\" \/>\n<meta property=\"og:description\" content=\"Welcome to the Autumn 2021 edition of Haavind\u2019s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published twice a year since 2016.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Haavind EN\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-15T10:39:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-21T12:50:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/\",\"name\":\"New edition of Haavind\u2019s Pharma Report - Haavind EN\",\"isPartOf\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg\",\"datePublished\":\"2021-10-15T10:39:12+00:00\",\"dateModified\":\"2022-07-21T12:50:50+00:00\",\"author\":{\"@id\":\"\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/#primaryimage\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg\",\"contentUrl\":\"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg\",\"width\":1000,\"height\":640},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/haavind.stage01.dekodes.no\/en\/#website\",\"url\":\"https:\/\/haavind.stage01.dekodes.no\/en\/\",\"name\":\"Haavind EN\",\"description\":\"-\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/haavind.stage01.dekodes.no\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New edition of Haavind\u2019s Pharma Report - Haavind EN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/","og_locale":"en_US","og_type":"article","og_title":"New edition of Haavind\u2019s Pharma Report","og_description":"Welcome to the Autumn 2021 edition of Haavind\u2019s Pharma Report. Pharma Report is a retrospective, report on legal developments in Norway relevant for the pharmaceutical sector, covering topics both within regulatory affairs and intellectual property. The report has been published twice a year since 2016.","og_url":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/","og_site_name":"Haavind EN","article_published_time":"2021-10-15T10:39:12+00:00","article_modified_time":"2022-07-21T12:50:50+00:00","og_image":[{"width":1000,"height":640,"url":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/","url":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/","name":"New edition of Haavind\u2019s Pharma Report - Haavind EN","isPartOf":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/#primaryimage"},"image":{"@id":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/#primaryimage"},"thumbnailUrl":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg","datePublished":"2021-10-15T10:39:12+00:00","dateModified":"2022-07-21T12:50:50+00:00","author":{"@id":""},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/new-edition-of-haavinds-pharma-report\/#primaryimage","url":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg","contentUrl":"https:\/\/haavind.stage01.dekodes.no\/content\/uploads\/sites\/2\/2022\/06\/1000x640-Media-Law-report-autumn-21.jpg","width":1000,"height":640},{"@type":"WebSite","@id":"https:\/\/haavind.stage01.dekodes.no\/en\/#website","url":"https:\/\/haavind.stage01.dekodes.no\/en\/","name":"Haavind EN","description":"-","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/haavind.stage01.dekodes.no\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1115"}],"collection":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/comments?post=1115"}],"version-history":[{"count":1,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1115\/revisions"}],"predecessor-version":[{"id":3668,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/posts\/1115\/revisions\/3668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/media\/1810"}],"wp:attachment":[{"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/media?parent=1115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/categories?post=1115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/tags?post=1115"},{"taxonomy":"sector","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/sector?post=1115"},{"taxonomy":"speciality","embeddable":true,"href":"https:\/\/haavind.stage01.dekodes.no\/en\/wp-json\/wp\/v2\/speciality?post=1115"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}